Login to Your Account



BT Pharma Completes €2.8M Financing Round

By James Etheridge


Wednesday, September 24, 2008

No Abstract

 

BioWorld International Correspondent

PARIS - BT Pharma SA, which is developing novel immuno-therapeutics for HPV-related diseases and cancers, completed a new funding round in which it raised €2.8 million (US$4 million).

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription